Northwest Biotherapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of NWBO for the last quarter is 445.00 k USD, and it's 9.61% higher compared to the previous quarter. The net income of Q4 23 is -18.92 M USD.